EUVIMEDEUVIMED entdecken
Crossref

Multifunctional RuO 2 Sensitized Co 3 O 4 Core‐Shell Sonozyme Heterojunctions for Sonodynamic and Nanocatalytic Co‐Amplified Immunotherapy

Guijun Zou, Nan Wang, Rui Ma, Bijiang Geng iD, Bing Ma, Chaojun Zhang

Small · 2025

DOI: 10.1002/smll.202507712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2025. Verfasst von Guijun Zou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, the First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China. Hauptthemen laut MEDLINE: Immunotherapy, Oxides, Cobalt, Ruthenium Compounds. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is believed that reactive oxygen species (ROS)‐mediated immunogenic cell death (ICD) can promote DC maturation and initiate cytotoxic T lymphocytes infiltration, but the limited ROS generation and immunosuppressive tumor microenvironments (TME) restrict the effectiveness of sonodynamic and nanocatalytic therapy (SDT/NCT). Herein, RuO 2 shell is utilized as the auxiliary sonosensitizers and nanozymes to sensitize Co 3 O 4 core for the construction of core‐shell Co 3 O 4 @RuO 2 heterojunction sonozymes. Enhanced sonodynamic and multienzyme‐mimic activities are observed in the heterojunction sonozymes, thanks to improved electron‐hole separation kinetics. Co 3 O 4 @RuO 2 ‐triggered cascade amplification of antitumor immune response is realized by the heterojunction construction, GSH depletion, and relief of hypoxia co‐augmented ROS yield, which significantly induced a robust ICD effect. Significant antitumor effects have been observed to eliminate primary tumors and stop the growth of distant tumors through Co 3 O 4 @RuO 2 ‐mediated SDT and NCT co‐amplified immunotherapy. This study provides promising insights into the development of heterojunction sonozymes as a novel antitumor nanoplatform to induce durable and potent immune responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyOxidesCobaltRuthenium CompoundsAnimalsReactive Oxygen SpeciesCatalysisMiceCell Line, TumorHumansTumor Microenvironment

Stichwörter der Autor:innen

Co3O4RuO2heterojunction sonozymesimmunotherapysonodynamic therapy

Substanzen

Oxidescobalt oxideCobaltReactive Oxygen SpeciesRuthenium Compounds

Autor:innen und Institutionen

  • Department of General Surgery, the First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
  • Medicine School of Chinese PLA, Beijing, 100853, China.
  • Department of Obstetrics and Gynecology, the First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
  • School of Environmental and Chemical Engineering, Shanghai University, Shanghai, 200444, China.

ORCID-Profile: Bijiang Geng

Förderung

  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Zou, G., Wang, N., Ma, R., Geng, B., Ma, B., & Zhang, C. (2025). Multifunctional RuO 2 Sensitized Co 3 O 4 Core‐Shell Sonozyme Heterojunctions for Sonodynamic and Nanocatalytic Co‐Amplified Immunotherapy. Small. https://doi.org/10.1002/smll.202507712

Vancouver

Zou G, Wang N, Ma R, Geng B, Ma B, Zhang C. Multifunctional RuO 2 Sensitized Co 3 O 4 Core‐Shell Sonozyme Heterojunctions for Sonodynamic and Nanocatalytic Co‐Amplified Immunotherapy. Small. 2025. doi:10.1002/smll.202507712

BibTeX
@article{Zou2025,
  author = {Zou, Guijun and Wang, Nan and Ma, Rui and Geng, Bijiang and Ma, Bing and Zhang, Chaojun},
  title = {Multifunctional RuO 2 Sensitized Co 3 O 4 Core‐Shell Sonozyme Heterojunctions for Sonodynamic and Nanocatalytic Co‐Amplified Immunotherapy},
  journal = {Small},
  year = {2025},
  doi = {10.1002/smll.202507712}
}
Kostenlos starten →